{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:19:53Z","timestamp":1772792393919,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ghir.2011.12.001","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T05:36:06Z","timestamp":1325828166000},"page":"17-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of coagulation and fibrinolytic parameters in adult onset GH deficiency and the effects of GH replacement therapy: A placebo controlled study"],"prefix":"10.1016","volume":"22","author":[{"given":"Ilkay","family":"Cakir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Tanriverdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuleyha","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leylagul","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Eser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kursad","family":"Unluhizarci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahrettin","family":"Kelestimur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ghir.2011.12.001_bb0005","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2265.2005.02283.x","article-title":"The effects of 12months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency","volume":"62","author":"Tanriverdi","year":"2005","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"Suppl. A","key":"10.1016\/j.ghir.2011.12.001_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-6374(99)80005-7","article-title":"High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results","volume":"9","author":"Erfurth","year":"1999","journal-title":"Growth Horm. IGF Res."},{"issue":"2","key":"10.1016\/j.ghir.2011.12.001_bb0015","first-page":"574","article-title":"Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors","volume":"85","author":"Bulow","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ghir.2011.12.001_bb0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ghir.2008.05.002","article-title":"Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly","volume":"19","author":"Tanriverdi","year":"2009","journal-title":"Growth Horm. IGF Res."},{"issue":"8710","key":"10.1016\/j.ghir.2011.12.001_bb0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ghir.2011.12.001_bb0030","first-page":"118","article-title":"Body composition, serum IGF-1 and leptin level changes in amateur boxers: retired boxers have risk factors for cardiovascular disorder","volume":"4","author":"Tanriverdi","year":"2008","journal-title":"Obes. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2011.12.001_bb0035","first-page":"85","article-title":"Fibrinolytic factors and atherothrombotic events: epidemiological evidence","volume":"32","author":"Folsom","year":"2000","journal-title":"Ann. Med."},{"key":"10.1016\/j.ghir.2011.12.001_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1475-2840-8-48","article-title":"Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes \u2014 a two year follow-up of 243 patients","volume":"8","author":"Jax","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"issue":"6","key":"10.1016\/j.ghir.2011.12.001_bb0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1507\/endocrj.52.709","article-title":"Massive cardiac thrombosis in a patient with Sheehan's syndrome","volume":"52","author":"Tanriverdi","year":"2005","journal-title":"Endocr. J."},{"issue":"Suppl. A","key":"10.1016\/j.ghir.2011.12.001_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1096-6374(98)80005-1","article-title":"The Growth Hormone Research Society consensus guidelines for the diagnosis and treatment of adult GH deficiency","volume":"8","author":"Hartman","year":"1998","journal-title":"Growth Horm. IGF Res."},{"issue":"3","key":"10.1016\/j.ghir.2011.12.001_bb0055","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.ATV.14.3.434","article-title":"High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults","volume":"14","author":"Johansson","year":"1994","journal-title":"Arterioscler. Thromb."},{"issue":"5","key":"10.1016\/j.ghir.2011.12.001_bb0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1365-2265.2000.01002.x","article-title":"Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement","volume":"52","author":"Kvasnicka","year":"2000","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"9","key":"10.1016\/j.ghir.2011.12.001_bb0065","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1210\/jc.2007-0609","article-title":"Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency","volume":"92","author":"Devin","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2011.12.001_bb0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.thromres.2009.06.018","article-title":"Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy","volume":"124","author":"Di Minno","year":"2009","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.ghir.2011.12.001_bb0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0038-1650594","article-title":"Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults","volume":"76","author":"Johansson","year":"1996","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.ghir.2011.12.001_bb0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-2007-1002144","article-title":"Haemostatic mechanisms are normal despite increased vascular mortality in hypopituitary adults","volume":"25","author":"Beshyah","year":"1993","journal-title":"Horm. Metab. Res."},{"issue":"6","key":"10.1016\/j.ghir.2011.12.001_bb0085","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2265.2006.02518.x","article-title":"Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency","volume":"64","author":"Gomez","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"3","key":"10.1016\/j.ghir.2011.12.001_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.14310\/horm.2002.11183","article-title":"Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults","volume":"5","author":"Miljic","year":"2006","journal-title":"Hormones (Athens)"},{"issue":"1","key":"10.1016\/j.ghir.2011.12.001_bb0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1210\/jc.2004-0477","article-title":"Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular risk","volume":"90","author":"Reis","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2011.12.001_bb0100","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1016\/j.thromres.2010.08.028","article-title":"Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy; correlations with PAI-1 and t-PA plasma levels","volume":"126","author":"Di Minno","year":"2010","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.ghir.2011.12.001_bb0105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1365-2141.2001.02813.x","article-title":"A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state","volume":"113","author":"Dykes","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.ghir.2011.12.001_bb0110","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1073\/pnas.78.4.2512","article-title":"High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein","volume":"78","author":"Dahlback","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.ghir.2011.12.001_bb0115","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood-2003-05-1551","article-title":"Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex","volume":"15","author":"Rezende","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ghir.2011.12.001_bb0120","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V68.6.1218.1218","article-title":"Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor","volume":"68","author":"Sakata","year":"1986","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ghir.2011.12.001_bb0125","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1365-2516.2008.01775.x","article-title":"Protein S deficiency: a clinical perspective","volume":"14","author":"ten Kate","year":"2008","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.ghir.2011.12.001_bb0130","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI111632","article-title":"Familial protein S deficiency is associated with recurrent thrombosis","volume":"74","author":"Comp","year":"1984","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ghir.2011.12.001_bb0135","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood.V64.6.1297.1297","article-title":"Plasma protein S deficiency in familial thrombotic disease","volume":"64","author":"Schwarz","year":"1984","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ghir.2011.12.001_bb0140","first-page":"144","article-title":"Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study","volume":"28","author":"Girolami","year":"1989","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ghir.2011.12.001_bb0145","first-page":"206","article-title":"Hereditary protein S deficiency in young adults with arterial occlusive disease","volume":"22","author":"Allaart","year":"1990","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.ghir.2011.12.001_bb0150","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MOH.0b013e328309ec97","article-title":"Regulation of coagulation by protein S","volume":"15","author":"Castoldi","year":"2008","journal-title":"Curr. Opin. Hematol."},{"issue":"7","key":"10.1016\/j.ghir.2011.12.001_bb0155","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-2000-8145","article-title":"Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly","volume":"108","author":"Sartorio","year":"2000","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"11","key":"10.1016\/j.ghir.2011.12.001_bb0160","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-125-11-199612010-00003","article-title":"Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial","volume":"1","author":"Baum","year":"1996","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.ghir.2011.12.001_bb0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2265.1998.00439.x","article-title":"Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults","volume":"48","author":"Kann","year":"1998","journal-title":"Clin. Endocrinol. (Oxf)"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637411001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637411001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:46:57Z","timestamp":1761086817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637411001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1096637411001201"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2011.12.001","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of coagulation and fibrinolytic parameters in adult onset GH deficiency and the effects of GH replacement therapy: A placebo controlled study","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2011.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}